Timing of CAR-T therapy in follicular lymphoma

被引:0
|
作者
Moustafa, Muhamad Alhaj [1 ]
机构
[1] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA
关键词
Follicular lymphoma; CAR T therapy; relapsed; refractory; RITUXIMAB; RISK;
D O I
10.1080/14737140.2023.2185222
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:347 / 349
页数:3
相关论文
共 50 条
  • [31] The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management
    Anurogo, Dito
    Luthfiana, Dewi
    Anripa, Nuralfin
    Fauziah, Apriliani Ismi
    Soleha, Maratu
    Rahmah, Laila
    Ratnawati, Hana
    Wargasetia, Teresa Liliana
    Pratiwi, Sari Eka
    Siregar, Riswal Nafi
    Sholichah, Ratis Nour
    Maulana, Muhammad Sobri
    Ikrar, Taruna
    Chang, Yu Hsiang
    Qiu, Jiantai Timothy
    ADVANCED PHARMACEUTICAL BULLETIN, 2024, 14 (02) : 314 - 330
  • [32] Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma
    Stepanov, Alexey, V
    Markov, Oleg, V
    Chernikov, Ivan, V
    Gladkikh, Daniil, V
    Zhang, Hongkai
    Jones, Teresa
    Sen'kova, Alexandra, V
    Chernolovskaya, Elena L.
    Zenkova, Marina A.
    Kalinin, Roman S.
    Rubtsovas, Maria P.
    Meleshko, Alexander N.
    Genkin, Dmitry D.
    Belogurov, Alexey A., Jr.
    Xie, Jia
    Gabibov, Alexander G.
    Lerner, Richard A.
    SCIENCE ADVANCES, 2018, 4 (11):
  • [33] Two for one? CAR-T therapy for lymphoma benefits concurrent autoimmune disorders
    Veronika Bachanova
    Patrick H. Nachman
    Bone Marrow Transplantation, 2023, 58 : 1175 - 1176
  • [34] Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T
    Crees, Zachary D.
    Ghobadi, Armin
    CANCERS, 2021, 13 (20)
  • [35] Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy
    Rahul Banerjee
    Victoria Wang
    Chiung-Yu Huang
    Divita Pandita
    Michelle K. Leonard
    Siobhan LaRue
    Michael Ahmadi
    Lawrence Kaplan
    Weiyun Z. Ai
    Bita Fakhri
    Michael Spinner
    Madhav Rao Seshadri
    Miguel Hernandez Pampaloni
    Charalambos Babis Andreadis
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3349 - 3353
  • [36] CD19-Targeting CAR-T Cell Therapy in CNS Lymphoma
    Siddiqi, Tanya
    Wang, Xiuli
    Palmer, Joycelynne
    Popplewell, Leslie L.
    Nikolaenko, Liana
    Herrera, Alex F.
    Budde, Lihua E.
    Lim, Laura
    Vyas, Vibhuti
    Brown, Christine E.
    Forman, Stephen J.
    BLOOD, 2019, 134
  • [37] Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy
    Banerjee, Rahul
    Wang, Victoria
    Huang, Chiung-Yu
    Pandita, Divita
    Leonard, Michelle K. K.
    LaRue, Siobhan
    Ahmadi, Michael
    Kaplan, Lawrence
    Ai, Weiyun Z. Z.
    Fakhri, Bita
    Spinner, Michael
    Seshadri, Madhav Rao
    Pampaloni, Miguel Hernandez
    Andreadis, Charalambos Babis
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3349 - 3353
  • [38] Cardiotoxicity after CAR-T Cell Therapy in cardiac Lymphoma: a Case Report
    Koch, C.
    Montrasio, G.
    Scherr, B. F.
    Schimmer, R.
    Manz, M. G.
    Matter, C. M.
    Muller, A. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 123 - 123
  • [39] Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma
    Kallam, Avyakta
    Vose, Julie M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (12): : 751 - 757
  • [40] Biomarkers for CAR-T Cell Therapy
    不详
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 123 - 124